Kevin Koch, President and CEO at Edgewise Therapeutics, Inc. (EWTX), sold 6,304 shares at $18.91 ($119K) on 2024-05-02, disclosed to the SEC on 2024-05-03.
Open-market sale of $119k EWTX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.91 | 3,152 | $60K | 50.0% |
| 2 | $18.91 | 3,152 | $60K | 50.0% |
| Total | $18.91 avg | 6,304 | $119K | 100% |
| Filing → |
| EWTX | SELL | 2025-05-07 | $141K | — | Filing → |
| EWTX | SELL | 2025-03-11 | $3K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $547K | — | Filing → |